Pharmaxis Balance Sheet - Annual (OTCMKTS:PXSLY)

Add to My Stocks
$3.95 $0 (0%) PXSLY stock closing price Sep 18, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Pharmaxis balance sheet. Financial strength can be guaged by performing Pharmaxis stock analysis and by analyzing the balance sheet. A company releases its balance sheet every year along with its annual results. Pharmaxis had a long term debt of $6.23M at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Pharmaxis operating cash flow and Pharmaxis revenue also. Pharmaxis debt to equity ratio is .

View latest 10 year balance sheet data to check Pharmaxis financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jul - Jun2017201620152014201320122011201020092008
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods1.03M---------
Notes Receivable----------
Other Current Assets-----4.16M----
Total Current Assets
Property Plant & Equipment30.06M28.82M--------
Accumulated Depreciation18.86M15.86M--------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets1.07M--1.97M2.87M-2.02M1.41M-1.36M
Deferred Charges----------
Deposits & Other Assets-----2.68M----
Total Assets
Notes Payable----------
Accounts Payable5.14M3.65M4.85M5.19M6.28M6.18M6.98M7.5M-5.11M
Current Portion Long-Term Debt1.25M1.02M--------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities1.53M3.34M1.3M1.66M1.9M-----
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt6.23M6.74M8.47M10M11.87M12.54M12.58M11.6M--
Non-Current Capital Leases----------
Other Long-Term Liabilities17.43M17.81M23.41M27.09M24.87M3.07M3.24M3.02M--
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net259.81M251.07M288.55M316.46M354.03M355.64M264.77M235.59M-174.43M
Capital Surplus----------
Retained Earnings-271.86M-249.36M-272.79M-316.14M-300.43M-257.05M-208.04M-145.13M--74.36M
Treasury Stock----------
Other Liabilities14.71M13.52M14.65M16.26M16.15M14.79M13.34M11M-6.66M
Shareholders Equity2.65M15.24M30.41M16.59M69.74M113.39M70.07M101.46M104.64M106.73M
Total Liabilities & Shareholders Equity34.25M47.83M69.12M61.29M115.34M136M93.56M124.18M124.63M112.04M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Pharmaxis stock price, and Pharmaxis historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Pharmaxis PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Pharmaxis owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for PXSLY stock as of 2017 is $34.25M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Pharmaxis is $31.59M. Shareholders' equity comes under liabilities as it is money the company owes the holders of PXSLY stock.

Pharmaxis Balance Sheet - Key Ratios